{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:54:25Z","timestamp":1787169265277,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473280"],"award-info":[{"award-number":["81473280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603186"],"award-info":[{"award-number":["81603186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1608283"],"award-info":[{"award-number":["U1608283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biopha.2018.07.068","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T23:26:29Z","timestamp":1532993189000},"page":"1760-1766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Involvement of organic cation transporter 2 in the metformin-associated increased lactate levels caused by contrast-induced nephropathy"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-7488","authenticated-orcid":false,"given":"Shilei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1644-0679","authenticated-orcid":false,"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.07.068_bib0005","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.2337\/dc18-S005","article-title":"Prevention or delay of type 2 diabetes: standards of medical care in diabetes-2018","volume":"41","author":"A. American Diabetes","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.biopha.2018.07.068_bib0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/EDE.0000000000000634","article-title":"Metformin to treat cancer: misstep in translational research from observational studies","volume":"28","author":"Suissa","year":"2017","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.biopha.2018.07.068_bib0015","article-title":"Metformin-associated lactic acidosis and acute kidney injury","volume":"33","author":"Greco","year":"2016","journal-title":"Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia"},{"issue":"2","key":"10.1016\/j.biopha.2018.07.068_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-associated lactic acidosis: current perspectives on causes and risk","volume":"65","author":"DeFronzo","year":"2016","journal-title":"Metabolism"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.07.068_bib0025","first-page":"45","article-title":"Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review","volume":"17","author":"Renda","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.068_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.068_bib0035","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2133\/dmpk.20.379","article-title":"Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1","volume":"20","author":"Kimura","year":"2005","journal-title":"Drug Metab. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.068_bib0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/bcp.12079","article-title":"Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters","volume":"76","author":"Grun","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.068_bib0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/aps.2009.189","article-title":"SLC22A2 gene 808 G\/T variant is related to plasma lactate concentration in Chinese type 2 diabetics treated with metformin","volume":"31","author":"Li","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.068_bib0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40291-014-0126-z","article-title":"Polymorphism of organic cation transporter 2 improves glucose-lowering effect of metformin via influencing its pharmacokinetics in Chinese type 2 diabetic patients","volume":"19","author":"Hou","year":"2015","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.biopha.2018.07.068_bib0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2016.06.076","article-title":"Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: amulticenter study","volume":"220","author":"Zeller","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.068_bib0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5527\/wjn.v6.i3.86","article-title":"Contrast-induced acute kidney injury: a review of practical points","volume":"6","author":"Ozkok","year":"2017","journal-title":"World J. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.068_bib0065","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1124\/jpet.106.113076","article-title":"Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices","volume":"321","author":"Nozaki","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2018.07.068_bib0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1752-1947-8-159","article-title":"Metformin-associated lactic acidosis presenting as an ischemic gut in a patient who then survived a cardiac arrest: a case report","volume":"8","author":"Ncomanzi","year":"2014","journal-title":"J. Med. Case Rep."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.068_bib0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jcpt.12187","article-title":"Pharmacist review prevents evolving metformin-associated lactic acidosis","volume":"39","author":"Naunton","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.068_bib0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/dc15-0488","article-title":"The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies","volume":"39","author":"Buse","year":"2016","journal-title":"Diabetes Care"},{"issue":"Pt 3","key":"10.1016\/j.biopha.2018.07.068_bib0085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.068_bib0090","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1172\/JCI117421","article-title":"Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat","volume":"94","author":"Agmon","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.068_bib0095","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.102.034140","article-title":"Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin","volume":"302","author":"Wang","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.068_bib0100","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1124\/mol.63.4.844","article-title":"Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin","volume":"63","author":"Wang","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.068_bib0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/clpt.2009.92","article-title":"The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin","volume":"86","author":"Tzvetkov","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.068_bib0110","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1124\/mol.109.056242","article-title":"Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin","volume":"75","author":"Tsuda","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"24","key":"10.1016\/j.biopha.2018.07.068_bib0115","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic acidosis","volume":"371","author":"Kraut","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218332335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218332335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T15:34:34Z","timestamp":1750865674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218332335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":23,"alternative-id":["S0753332218332335"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.068","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of organic cation transporter 2 in the metformin-associated increased lactate levels caused by contrast-induced nephropathy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}